Skip to main content

You are here

Newborn Screening Program



Newborn screening refers to medical tests, the majority of which are genetic, performed to identify babies with certain disorders, which without intervention, may permanently impact newborns and their families. Early recognition and treatment of most of these disorders leads to a better outcome for the newborn. The Newborn Screening Program’s goal is to help affected babies live as long and normal of a life as possible.

The Newborn Screening Program effectively identifies babies with certain disorders and is required for all newborns born in New York State unless the parents confirm, in writing, that they have a religious objection.

Quick Facts about Newborn Screening:

  • A small blood sample is collected by pricking your newborn’s heel usually 24-36 hours after birth.
  • The blood is used to screen for 50 different disorders.
  • There is no charge to you for this service.
  • Most newborns will not have one of these disorders.
  • Newborns with one of these disorders may look healthy at birth, which is why the testing must be performed to find those with a disorder. The earlier treatment is started, the better the outcome is for your newborn.
  • Screening is designed to identify all newborns with the potential for one of these disorders. Further testing is then required to verify whether or not your newborn has the disorder.

We work closely with health care providers to ensure newborns with abnormal test results receive appropriate confirmatory diagnoses and treatment.

No test is perfect. If your newborn’s healthcare provider suspects there is a problem or your newborn does not seem right despite a normal newborn screening result, your newborn may need further testing.

CLIA # 33D2005937 | PFI # 8523

Program Updates

image of baby

Newborn Screening's Annual Reports

These newborn screening annual reports are provided for informational use only, and should not be used for research purposes. Because of the way the report is constructed, the values for individual conditions are subject to change. Please contact the program for up-to-date information.

read more
Change in Newborn Screening Program's Hemoglobinopathy Algorithm

Changes to the New York State Newborn Screening Program's Hemoglobinopathy Algorithm

Changes described are effective for specimens received and tested as of September 25, 2019.

Newborn Screening

Now Available - Resources Explaining February 2019 Regulation Changes

The first in a series of six webinars and associated power point presentations is available. Topics include:

  • Specimen collection, shipping, tracking and resulting
  • Babies in the NICU
  • Requests for repeats
  • ...
read more
Cystic Fibrosis Algorithm Changes

Cystic Fibrosis Algorithm Changes

As of July 1, 2019, the changes outlined in the Letter to Healthcare Providers are effective.